Breast cancer drug repurposed for congenital hyperinsulinism
In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings were published in the New England Journal of Medicine. As the patient wasn’t responding to conventional medical therapies, the Sidra… Read More